Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection

AIDS

Volumn 14, Issue 2, 2000, Pages 197-201

  Law, Matthew G ^a   Li, Yueming ^a   McDonald, Ann M ^a   Cooper, David A ^a   Kaldor, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antiretroviral therapy; Models projections; Surveillance

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUSTRALIA; DATA ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; AUSTRALIA; DATA COLLECTION; HUMANS; INCIDENCE; MODELS, STATISTICAL; POPULATION SURVEILLANCE;

EID: 0034004585     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200001280-00016     Document Type: Article

References (20)

1. 1. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe: Quarterly Report No. 60, 31 December 1998. Saint Maurice, France: European Centre for the Epidemiological Monitoring of AIDS; 1998.
2. 2. Health Canada. HIV and AIDS in Canada: Surveillance Report to June 30, 1998. Ottawa, Ontario, Canada: Division of HIV/AIDS Surveillance, Bureau of HIV/AIDS, STD and TB, LCDC, Health Canada; 1998.
3. 3. National Centre in HIV Epidemiology and Clinical Research. An Epidemiological Assessment of the HIV Epidemic in Australia. Evaluation of the National HIV/AIDS Strategy 1993-94 to 1995-96 Technical Appendix 1. Canberra: Commonwealth Department of Health and Family Services; 1996.
4. 4. National Working Group on HIV Projections. Estimates and Projections of the HIV Epidemic in Australia, 1981-1994. Technical Report 1. Sydney: National Centre in HIV Epidemiology and Clinical Research; 1992.
5. 5. Becker NG, Watson LF, Marschner IC, Motika M, Egerton L, Carlin J. Assessing the extent of the Australian HIV epidemic from AIDS surveillance data. Aust J Public Health 1993, 17:226-231.
6. 6. Centers for Disease Control and Prevention. Update on acquired immunodeficiency syndrome (AIDS). MMWR 1982, 31:507-514.
7. 7. Whyte BM, Cooper DA. The surveillance definition of the acquired immunodeficiency syndrome and the clinical classification of infection with the human immunodeficiency virus type 1. Med J Aust 1988, 149:10-17.
8. 8. Australian National Council on AIDS. Definition of HIV infection and AIDS defining illnesses. ANCA Bull 1994, 18:1-6.
9. 9. Brookmeyer R, Liao J. The analysis of delays in disease reporting: methods and results for the acquired immunodeficiency syndrome. Am J Epidemiol 1990, 132:355-365.
10. 10. Bacchetti P. Reporting delays of deaths with AIDS in the United States. J Acquir Immune Defic Syndr Hum Retrovir 1996, 13:363-367.
11. 11. Becker NG, Watson LF, Carlin JB. A method of non-parametric back-projection and its application to AIDS data. Stat Med 1991, 10:1527-1542.
12. 12. Rosenberg PS, Gail MH, Carroll RJ. Estimating HIV prevalence and projecting AIDS incidence in the United States: a model that accounts for therapy and changes in the surveillance definition of AIDS. Stat Med 1992, 11:1633-1655.
13. 13. Law MG. Progression to AIDS: a comparison of Australian and overseas findings. Presented at Sixth Annual Conference of the Australasian Society for HIV Medicine, Sydney 1994.
14. 14. Alcabes P, Munoz A, Vlahov D, Freidlan GH. Incubation period of Human Immunodeficiency Virus. Epidemiol Rev 1993, 15:303-318.
15. 15. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New Engl J Med 1990, 322:941-949.
16. 16. Cooper DA, Gatell JM, Kroon S, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New Engl J Med 1993, 322:941-949.
17. 17. Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994, 343:871-881.
18. 18. National Centre in HIV Epidemiology and Clinical Research (ed.). HIV/AIDS, Hepatitis C and Sexually Transmissible Infections in Australia: Annual Surveillance Report 1999. University of New South Wales, Sydney: National Centre in HIV Epidemiology and Clinical Research; 1999.
19. 19. McNulty A, Law MG, Bodsworth NJ, Cooper DA, Kaldor JM. Incidence of HIV infection in a cohort of homosexually active men. Aust NZ J Public Health 1997, 21:587-589.
20. 20. Rao CR. Linear Statistical Inference and its Applications, 2nd edition. New York: J Wiley and Sons, 1973.